Information Provided By: 
Fly News Breaks for February 19, 2019
PODD
Feb 19, 2019 | 07:38 EDT
Canaccord analyst Kyle Rose raised his price target on Insulet to $100 from $90 as he believes the company is in the early stages of a transformative 24-month period that will see meaningful global share gains and significant margin expansion. He also updated his model ahead of Q4 results to reflect a more conservative revenue ramp for 2019, which he believes positions the company as a beat-and-raise story going forward. Rose reiterated his Buy rating on Insulet shares.
News For PODD From the Last 2 Days
There are no results for your query PODD
